168 related articles for article (PubMed ID: 12002908)
1. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
[TBL] [Abstract][Full Text] [Related]
3. Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Berg HF; Maraha B; Scheffer GJ; Quarles-van Ufford M; Vandenbroucke-Grauls CM; Peeters MF; Kluytmans JA
Clin Infect Dis; 2005 Feb; 40(3):358-65. PubMed ID: 15668857
[TBL] [Abstract][Full Text] [Related]
4. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
[TBL] [Abstract][Full Text] [Related]
5. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
Cannon CP; Braunwald E; McCabe CH; Grayston JT; Muhlestein B; Giugliano RP; Cairns R; Skene AM;
N Engl J Med; 2005 Apr; 352(16):1646-54. PubMed ID: 15843667
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin for the secondary prevention of coronary events.
Grayston JT; Kronmal RA; Jackson LA; Parisi AF; Muhlestein JB; Cohen JD; Rogers WJ; Crouse JR; Borrowdale SL; Schron E; Knirsch C;
N Engl J Med; 2005 Apr; 352(16):1637-45. PubMed ID: 15843666
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
[TBL] [Abstract][Full Text] [Related]
10. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
[TBL] [Abstract][Full Text] [Related]
11. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
[TBL] [Abstract][Full Text] [Related]
12. No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
Westerhout CM; Gnarpe J; Chang WC; FitzPatrick S; Barnathan ES; Boersma E; Califf RM; Wallentin L; Simoons ML; Armstrong PW;
Am Heart J; 2007 Aug; 154(2):306-12. PubMed ID: 17643581
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial in patients undergoing percutaneous coronary angioplasty: roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae.
Kaehler J; Haar A; Schaps KP; Gaede A; Carstensen M; Schalwat I; Koester R; Laufs R; Meinertz T; Terres W
Am Heart J; 2005 Nov; 150(5):987-93. PubMed ID: 16290983
[TBL] [Abstract][Full Text] [Related]
14. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
[TBL] [Abstract][Full Text] [Related]
15. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
[TBL] [Abstract][Full Text] [Related]
16. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial.
Joensen JB; Juul S; Henneberg E; Thomsen G; Ostergaard L; Lindholt JS
Atherosclerosis; 2008 Feb; 196(2):937-42. PubMed ID: 17418218
[TBL] [Abstract][Full Text] [Related]
17. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting.
Zairis MN; Papadaki OA; Psarogianni PK; Thoma MA; Andrikopoulos GK; Batika PC; Poulopoulou CG; Trifinopoulou KG; Olympios CD; Foussas SG
Am Heart J; 2003 Dec; 146(6):1082-9. PubMed ID: 14661003
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
[TBL] [Abstract][Full Text] [Related]
19. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
[TBL] [Abstract][Full Text] [Related]
20. Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.
Berg HF; Maraha B; van der Zee A; Gielis SK; Roholl PJ; Scheffer GJ; Peeters MF; Kluytmans JA
J Clin Microbiol; 2005 Mar; 43(3):1325-9. PubMed ID: 15750103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
